Latest filing published 02 Oct 2018 for Audentes Therapeutics, Inc., €78.
Filing timeline
BuySaleInsider track record
John T. Gray: trading record in brief
John T. Gray appears in our data through filings on Audentes Therapeutics, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 28 September 2018, with 2 filings.
No open-market purchase appears, only 1 sale worth €2,990. Outside the open market, there are 1 option exercise.
Most recently, on 2 October 2018, the filings show an option exercise worth €78 in Audentes Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John T. Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 87 shares@ US$1.052.6% of flowCommon StockSEC:0001209191-18-053463:0
- 87 shares@ US$40.0097.4% of flowCommon StockSEC:0001209191-18-053463:1
2 of 2 declarations